iShares U.S. Pharmaceuticals ETF

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…

Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its…

Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…

Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering…

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…

A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…

Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’